FDA Approves First Oral PCSK9 Inhibitor

• by Kathryn Wighton

• July 16, 2026

Could Pregnancy Complications Predict CVD Risk?

Investigators found that adding pregnancy-related and female-specific factors modestly improved postpartum cardiovascular risk prediction compared with traditional risk factors alone.

• by Andrea Surnit

• August 5, 2026

• 4 min

Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential

• by Hang Zhan, Die Li, Jiayao He, Yuzhuang Hu, Wei Jiang, Jiayu Zhang, Wei Chen, Weize Xu

• July 16, 2026

Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management

• by Omar El Khatib, Ashraf Al Azzoni, Ronney Shantouf, Bassam Atallah

• July 20, 2026